The latest price target for Aspira Womens Health (NASDAQ:AWH) was reported by Alliance Global Partners on August 14, 2024. The analyst firm set a price target for $5.50 expecting AWH to rise to within 12 months (a possible 554.76% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Aspira Womens Health (NASDAQ:AWH) was provided by Alliance Global Partners, and Aspira Womens Health maintained their buy rating.

There is no last upgrade for Aspira Womens Health

The last downgrade for Aspira Womens Health Inc happened on January 20, 2023 when Cantor Fitzgerald changed their price target from $3 to $2 for Aspira Womens Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on August 14, 2024 so you should expect the next rating to be made available sometime around August 14, 2025.

While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a maintained with a price target of $7.00 to $5.50. The current price Aspira Womens Health (AWH) is trading at is $0.84, which is out of the analyst’s predicted range.